Glutathione S-transferase gene polymorphisms and susceptibility to acute myeloid leukemia: Meta-analyses

Japanese Journal of Clinical Oncology

Volumn 44, Issue 11, 2014, Pages 1070-1081

  He, Hai Rong ^a   You, Hai Sheng ^a   Sun, Jin Yue ^a   Hu, Sa Sa ^a   Ma, Ying ^a   Dong, Ya Lin ^a   Lu, Jun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; GSTM1; GSTP1; GSTT1; Susceptibility

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; ISOLEUCINE; VALINE;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; DNA DAMAGE; DNA POLYMORPHISM; EAST ASIAN; FEMALE; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; RISK; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOLEUCINE; LEUKEMIA, MYELOID, ACUTE; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; VALINE;

EID: 84922391543     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyu121     Document Type: Article

References (42)

1. Zhou L, Zhu YY, Zhang XD, Li Y, Liu ZG. Risk effects of GST gene polymorphisms in patients with acute myeloid leukemia: a prospective study. Asian Pac J Cancer Prev 2013;14:3861-4.
2. Chauhan PS, Ihsan R, Yadav DS, et al. Association of glutathione S-transferase, EPHX, and p53 codon 72 gene polymorphisms with adult acute myeloid leukemia. DNA Cell Biol 2011;30:39-46.
3. Ishikawa K, Ishii H, Saito T. DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol 2006;25:406-11.
4. Kennedy RD, D'Andrea AD. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J Clin Oncol 2006;24:3799-808.
5. Bhatla D, Gerbing RB, Alonzo TA, et al. DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group. Leukemia 2008;22:265-72.
6. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
7. Mannervik B, Board PG, Hayes JD, Listowsky I, Pearson WR. Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 2005;401:1-8.
8. Alves S, Amorim A, Ferreira F, Norton L, PrataMJ. The GSTM1 and GSTT1 genetic polymorphisms and susceptibility to acute lymphoblastic leukemia in children from north Portugal. Leukemia 2002;16:1565-7.
9. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res 2001;482:21-6.
10. Sailaja K, Surekha D, Rao DN, Rao DR, Vishnupriya S. Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia. Asian Pac J Cancer Prev 2010;11:461-4.
11. Dunna NR, Vuree S, Kagita S, et al. Association of GSTP1 gene (I105V) polymorphism with acute leukaemia. J Genet 2012;91:e60-3.
12. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione -transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998;19:275-80.
13. Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, Garcia-Orad A. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia. Pharmacogenomics J 2012;13:498-506.
14. Gurion R, Gafter-Gvili A, Vidal L, et al. Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis. Haematologica 2013;98:95-102.
15. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
16. Allan JM, Wild CP, Rollinson S, et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapyinduced leukemia. Proc Natl Acad Sci USA 2001;98:11592-7.
17. Arruda VR, Lima CS, Grignoli CR, et al. Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur J Haematol 2001;66:383-8.
18. Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 2006;81:162-70.
19. Bolufer P, Collado M, Barragan E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 2007;92:308-14.
20. Chauhan PS, Ihsan R, Mishra AK, et al. High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia. Environ Mol Mutagen 2012;53:619-30.
21. Crump C, Chen C, Appelbaum FR, et al. Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev 2000;9:457-60.
22. D'Alo F, Voso MT, Guidi F, et al. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica 2004;89:664-70.
23. Dunna NR, Vure S, Sailaja K, et al. Deletion of GSTM1 and T1 genes as a risk factor for development of acute leukemia. Asian Pac J Cancer Prev 2013;14:2221-4.
24. Eyada TK, El Ghonemy EG, El Ghoroury EA, El Bassyouni SO, El Masry MK. Study of genetic polymorphism of xenobiotic enzymes in acute leukemia. Blood Coagul Fibrinolysis 2007;18:489-95.
25. Gra OA, Glotov AS, Kozhekbaeva Z, Makarova OV, Nasedkina TV. Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia. Mol Biol (Mosk) 2008;42:214-25.
26. Haase D, Binder C, Bunger J, et al. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 2002;26:249-54.
27. Kim HN, Kim NY, Yu L, et al. Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status. Leuk Lymphoma 2012;53:681-7.
28. Majumdar S, Mondal BC, Ghosh M, et al. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev 2008;17:125-32.
29. Muller P, Asher N, Heled M, Cohen SB, Risch A, Rund D. Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups. Leuk Res 2008;32:919-29.
30. Naoe T, Takeyama K, Yokozawa T, et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000;6:4091-5.
31. Rollinson S, Roddam P, Kane E, et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis 2000;21:43-7.
32. Sasai Y, Horiike S, Misawa S, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res 1999;23:975-81.
33. Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res 2004;10:2675-80.
34. Voso MT, Fabiani E, D'Alo' F, et al. Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol 2007;18:1523-8.
35. Xi YM, Shi XE, Zhang H, et al. Relation of GSTP1 and CYP2E1 polymorphisms with susceptibility to acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011;19:589-93.
36. Yang L, Zhang Y, Zhang MR, Xiao ZJ. Relationship between GSTT1, GSTM1 and NQO1 gene polymorphism and acute myeloid leukemia and recurrent chromosome translocations. Zhonghua Yi Xue Za Zhi 2005;85:2312-6.
37. Yuan XJ, Gu LJ, Xue HL, et al. Analysis on GST-Pi genetic polymorphism in children with acute leukemia. Zhonghua Yi Xue Za Zhi 2003;83:1863-6.
38. Zou LL, Lin GF, Ma QW, Zhang DS, Shen JH. Glutathione S-transferase T1, M1 gene polymorphism in leukemia patients in Shanghai area. Zhonghua Zhong Liu Za Zhi 2004;26:649-51.
39. Lemos MC, Cabrita FJ, Silva HA, Vivan M, Placido F, Regateiro FJ. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 1999;20:1225-9.
40. Ouerhani S, Nefzi MA, Menif S, et al. Influence of genetic polymorphisms of xenobiotic metabolizing enzymes on the risk of developing leukemia in a Tunisian population. Bull Cancer 2011;98: 95-106.
41. Das P, Shaik AP, Bammidi VK. Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia. Leuk Lymphoma 2009;50:1345-51.
42. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res 2000;464:65-76.